• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Uncategorized

Uncategorized

New discovery stops bacterial virus contamination

May 3, 2023 Microbiome Times

A new discovery by researchers at the University of Warwick could help stop bacteria being contaminated with viruses, reducing disruption and decreasing costs in industry and research. Bacteria are routinely used in biological and biomedical […]

Pharma & Human Health

Felix Biotechnology announces initiation of a Phase 1/2 study at Yale for targeted phage therapy in the treatment of P. aeruginosa infections

January 20, 2021 Microbiome Times

Felix Biotechnology announced the initiation of CYPHY, a Phase 1/2 investigator-initiated single center trial at Yale University for targeted phage therapy YPT-01 in the treatment of chronic P. aeruginosa infections in cystic fibrosis. This double-blind, […]

Editor's Choice

The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline

March 26, 2020 Luis Gosálbez

Introduction The microbiome is one of the hottest areas in biotechnology, as countless studies have linked its composition and activity with human disease1,2, especially in illnesses of poorly understood mechanisms, with high medical unmet needs. […]

  • Microbiome Drug Database Update: March 2021
    March 4, 2021
  • Microbiome-based diagnostics and biomarkers: Changing the paradigm in microbiology and medicine
    February 3, 2021
  • The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry
    October 26, 2020
  • The Microbiome Biotech Landscape: An Analysis of the Pharmaceutical Pipeline
    October 8, 2020
  • Microbiome after coronavirus: Investing in the power of microbes
    October 8, 2020
sign up

Sign up to the Microbiome Times newsletterÂ